Nuvation Bio, Inc. (NUVB)
4.73
+0.15
(+3.28%)
USD |
NYSE |
Jun 11, 14:09
Nuvation Bio SG&A Expense (Quarterly) : 38.31M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 38.31M |
| December 31, 2025 | 40.33M |
| September 30, 2025 | 37.36M |
| June 30, 2025 | 38.48M |
| March 31, 2025 | 35.39M |
| December 31, 2024 | 26.14M |
| September 30, 2024 | 19.58M |
| June 30, 2024 | 16.16M |
| March 31, 2024 | 7.357M |
| December 31, 2023 | 5.48M |
| September 30, 2023 | 7.778M |
| June 30, 2023 | 7.541M |
| March 31, 2023 | 7.734M |
| Date | Value |
|---|---|
| December 31, 2022 | 7.464M |
| September 30, 2022 | 8.044M |
| June 30, 2022 | 8.948M |
| March 31, 2022 | 7.463M |
| December 31, 2021 | 7.607M |
| September 30, 2021 | 5.669M |
| June 30, 2021 | 6.40M |
| March 31, 2021 | 4.605M |
| December 31, 2020 | 4.432M |
| September 30, 2020 | 2.919M |
| June 30, 2020 | 1.672M |
| March 31, 2020 | 1.925M |
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| SIGA Technologies, Inc. | 4.673M |
| Merck & Co., Inc. | 2.70B |
| Pfizer Inc. | 2.961B |
| Alumis, Inc. | 18.61M |
| ANI Pharmaceuticals, Inc. | 73.66M |